These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 4408328)

  • 1. Pharmacological and safety aspects of existing requirements and regulations when introducing a new drug.
    Kramer M
    Arzneimittelforschung; 1974 Apr; 24(4):504-8. PubMed ID: 4408328
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bioavailability, proof of efficacy and their consequences for drug legislation (author's transl)].
    Schnieders B
    Arzneimittelforschung; 1976; 26(1A):158-63. PubMed ID: 947195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Food and Drug Administration's requirements for approval of new dental drugs.
    Gilkes CC
    Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():5-12. PubMed ID: 1064180
    [No Abstract]   [Full Text] [Related]  

  • 4. Towards a more rational regulation of the development of new medicines. Report of a European workshop held in Sestri Levante, Italy, September 28-30, 1976.
    Eur J Clin Pharmacol; 1977 Mar; 11(3):233-8. PubMed ID: 852499
    [No Abstract]   [Full Text] [Related]  

  • 5. Food and Drug Administration regulations and licensure.
    Barker LF
    Fed Proc; 1975 May; 34(6):1522-4. PubMed ID: 1126452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolism of drugs and drug security].
    Rentsch GA
    Dtsch Med Wochenschr; 1975 Oct; 100(44):2285-92. PubMed ID: 1183328
    [No Abstract]   [Full Text] [Related]  

  • 8. Current status of international drug regulation.
    Lasagna L
    Med Mark Media; 1978 Feb; 13(2):37-8, 40, 42-5. PubMed ID: 10316569
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to the applicability of proposed large volume parenteral regulations to small volume parenteral drug products.
    Bull Parenter Drug Assoc; 1976; 30(6):265-79. PubMed ID: 1000103
    [No Abstract]   [Full Text] [Related]  

  • 10. The control of drugs and therapeutic freedom.
    Dunlop D
    Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA pressure?
    Appleton BL
    Nature; 1990 Mar; 344(6262):99. PubMed ID: 2308647
    [No Abstract]   [Full Text] [Related]  

  • 12. New regulations to speed drug approvals, improve safety monitoring.
    FDA Drug Bull; 1985 Apr; 15(1):2-3. PubMed ID: 3996801
    [No Abstract]   [Full Text] [Related]  

  • 13. Beware of new drugs, study suggests.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 May; 13(10):1-2, 5. PubMed ID: 12492085
    [No Abstract]   [Full Text] [Related]  

  • 14. How safe are they?
    Gorman C
    Time; 2004 Nov; 164(22):151. PubMed ID: 15631007
    [No Abstract]   [Full Text] [Related]  

  • 15. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 16. A product standards form for new radipharmaceuticals.
    Warbick A
    Am J Hosp Pharm; 1974 Feb; 31(2):165-6. PubMed ID: 4815850
    [No Abstract]   [Full Text] [Related]  

  • 17. [Problems in drug registration procedures and their significance for the physician (author's transl)].
    Preisig R
    Ther Umsch; 1974 Nov; 31(11):859-64. PubMed ID: 4428449
    [No Abstract]   [Full Text] [Related]  

  • 18. New classification of drugs.
    J Fla Med Assoc; 1972 Jan; 59(1):37. PubMed ID: 5058956
    [No Abstract]   [Full Text] [Related]  

  • 19. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.
    Simmons HE
    Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901
    [No Abstract]   [Full Text] [Related]  

  • 20. Provision of information on regulatory authorities' websites.
    Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E
    Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.